Aurinia Pharmaceuticals Stock Operating Margin
Aurinia Pharmaceuticals fundamentals help investors to digest information that contributes to Aurinia Pharmaceuticals' financial success or failures. It also enables traders to predict the movement of Aurinia Stock. The fundamental analysis module provides a way to measure Aurinia Pharmaceuticals' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Aurinia Pharmaceuticals stock.
Aurinia |
Aurinia Pharmaceuticals Company Operating Margin Analysis
Aurinia Pharmaceuticals' Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.
Current Aurinia Pharmaceuticals Operating Margin | 0.17 % |
Most of Aurinia Pharmaceuticals' fundamental indicators, such as Operating Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Aurinia Pharmaceuticals is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.
CompetitionBased on the recorded statements, Aurinia Pharmaceuticals has an Operating Margin of 0.1733%. This is 100.49% lower than that of the Biotechnology sector and 100.15% lower than that of the Health Care industry. The operating margin for all United States stocks is 103.15% lower than that of the firm.
Aurinia Operating Margin Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Aurinia Pharmaceuticals' direct or indirect competition against its Operating Margin to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Aurinia Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Aurinia Pharmaceuticals by comparing valuation metrics of similar companies.Aurinia Pharmaceuticals is currently under evaluation in operating margin category among its peers.
Aurinia Fundamentals
| Return On Equity | -0.0578 | ||||
| Return On Asset | -0.0216 | ||||
| Profit Margin | (0.10) % | ||||
| Operating Margin | 0.17 % | ||||
| Current Valuation | 884.54 M | ||||
| Shares Outstanding | 143.18 M | ||||
| Shares Owned By Insiders | 7.20 % | ||||
| Shares Owned By Institutions | 41.86 % | ||||
| Number Of Shares Shorted | 7.48 M | ||||
| Price To Earning | (4.83) X | ||||
| Price To Book | 2.95 X | ||||
| Price To Sales | 5.20 X | ||||
| Revenue | 175.51 M | ||||
| Gross Profit | 169.36 M | ||||
| EBITDA | (63.05 M) | ||||
| Net Income | (78.02 M) | ||||
| Cash And Equivalents | 391.51 M | ||||
| Cash Per Share | 2.76 X | ||||
| Total Debt | 97.61 M | ||||
| Debt To Equity | 0.02 % | ||||
| Current Ratio | 13.09 X | ||||
| Book Value Per Share | 2.71 X | ||||
| Cash Flow From Operations | (33.46 M) | ||||
| Short Ratio | 5.50 X | ||||
| Earnings Per Share | (0.15) X | ||||
| Target Price | 10.84 | ||||
| Number Of Employees | 300 | ||||
| Beta | 1.46 | ||||
| Market Capitalization | 1.15 B | ||||
| Total Asset | 548.06 M | ||||
| Retained Earnings | (942.32 M) | ||||
| Working Capital | 347.61 M | ||||
| Current Asset | 16.53 M | ||||
| Current Liabilities | 3.62 M | ||||
| Net Asset | 548.06 M |
Currently Active Assets on Macroaxis
| EBR | Centrais Electricas Brasileiras | |
| HE | Hawaiian Electric Industries | |
| VFC | VF Corporation | |
| BVHMF | Vistry Group PLC | |
| S | SentinelOne |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey. You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.
Other Tools for Aurinia Stock
When running Aurinia Pharmaceuticals' price analysis, check to measure Aurinia Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aurinia Pharmaceuticals is operating at the current time. Most of Aurinia Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Aurinia Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aurinia Pharmaceuticals' price. Additionally, you may evaluate how the addition of Aurinia Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency |